Cornercap Investment Counsel Inc Abb Vie Inc. Transaction History

Cornercap Investment Counsel Inc

$329 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $40,780 - $46,964	282 Added 1.55%	18,426 $2.94 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $87,411 - $104,829	632 Added 3.61%	18,144 $2.93 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $24,023 - $27,553	-179 Reduced 1.01%	17,512 $2.35 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $99,774 - $126,846	725 Added 4.27%	17,691 $2.71 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $189,127 - $234,653	-1,433 Reduced 7.79%	16,966 $2.75 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $191,440 - $242,227	1,782 Added 10.72%	18,399 $2.49 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.77 Million - $2.01 Million	16,617 New	16,617 $1.79 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $3.88 Million - $4.27 Million	-37,910 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $3.05 Million - $4.12 Million	37,910 New	37,910 $3.36 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $274,912 - $322,656	-3,200 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $234,784 - $314,176	3,200 New	3,200 $315,000
Q1 2020 May 11, 2020	SELL	$64.5 - $97.79 $2.78 Million - $4.21 Million	-43,035 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $183,642 - $229,776	-2,546 Reduced 5.59%	43,035 $3.81 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $2,519 - $3,028	40 Added 0.09%	45,581 $3.45 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $485,260 - $620,276	7,386 Added 19.36%	45,541 $3.31 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $1.24 Million - $1.46 Million	16,045 Added 72.57%	38,155 $3.08 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $276,756 - $341,315	3,555 Added 19.16%	22,110 $2.04 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $1.65 Million - $1.83 Million	18,555 New	18,555 $1.76 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $1.59 Million - $2.14 Million	-17,333 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $169,089 - $185,420	-1,888 Reduced 9.82%	17,333 $1.68 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $1.34 Million - $1.71 Million	19,221	19,221 $1.71 Million

Others Institutions Holding ABBV

# of Institutions

3,891

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Account